ED
Chugai Pharmaceutical president Osamu Okuda speaks at the FCCJ for COVID-19 drugs
August 27, 2021, Tokyo, Japan - Japan's drug maker Chugai Pharmaceutical president Osamu Okuda speaks at the Foreign Correspondents' Club of Japan in Tokyo on Friday, August 27, 2021. Chugai, a subsidiary of Swiss drug giant Hoffman-La Roche provides an antibody cocktail drug "Ronapreve" which is developed by U.S. biotechnology company Regeneron Pharmaceuticals and Roche for the COVID-19 patients to Japan through the government. (Photo by Yoshio Tsunoda/AFLO)
Details
ID
167943936
Collection
License type
Editorial
Photographer
Creation date
27-08-2021
Contact Aflo for all commercial uses.
More
Top Categories